1ST Source Bank Sells 105 Shares of HCA Healthcare, Inc. (NYSE:HCA)

1ST Source Bank lowered its position in HCA Healthcare, Inc. (NYSE:HCA) by 1.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 8,268 shares of the company’s stock after selling 105 shares during the quarter. 1ST Source Bank’s holdings in HCA Healthcare were worth $2,482,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of HCA. Whipplewood Advisors LLC bought a new stake in shares of HCA Healthcare in the 4th quarter worth approximately $31,000. Tidemark LLC bought a new position in shares of HCA Healthcare during the 4th quarter worth approximately $36,000. Legacy Investment Solutions LLC bought a new position in shares of HCA Healthcare during the 3rd quarter worth approximately $39,000. Activest Wealth Management lifted its position in shares of HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after buying an additional 125 shares during the period. Finally, Pinnacle Bancorp Inc. lifted its position in shares of HCA Healthcare by 50.0% during the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock worth $45,000 after buying an additional 50 shares during the period. Institutional investors own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

HCA has been the subject of several research analyst reports. Wells Fargo & Company downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and cut their price objective for the company from $400.00 to $320.00 in a research report on Monday, November 25th. Truist Financial cut their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $380.00 price objective on shares of HCA Healthcare in a research report on Tuesday, December 17th. Bank of America cut their price objective on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research report on Monday, January 27th. Finally, Raymond James downgraded HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. One investment analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $385.67.

Insiders Place Their Bets

In other news, SVP Jennifer Berres sold 9,533 shares of the business’s stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the sale, the senior vice president now directly owns 15,412 shares in the company, valued at $4,971,757.08. The trade was a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Stock Up 1.6 %

Shares of HCA Healthcare stock opened at $319.82 on Monday. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The business has a fifty day simple moving average of $319.00 and a 200 day simple moving average of $344.95. The stock has a market cap of $78.74 billion, a PE ratio of 14.56, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter last year, the firm earned $5.90 EPS. Research analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be issued a dividend of $0.72 per share. The ex-dividend date is Monday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a yield of 0.90%. HCA Healthcare’s payout ratio is currently 13.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.